Fundamentals

Interim Monitoring vs. Annual Full Review: What You Should Expect Between Opinions

How quarterly monitoring catches reserve drift before it compounds, what it includes that a full annual review does not, and what to require from your actuary between opinions.

By Sam · April 2026 · 13 min read

Most self-insured programs receive one full actuarial reserve study per year. That study selects methods, sets development patterns, applies trend assumptions, and produces the IBNR number that flows into the balance sheet and the funding recommendation that flows into the budget. It is the single most consequential actuarial deliverable a risk manager or CFO receives.

But claims do not wait for the annual study. Between opinions, new claims arrive, open claims develop, large losses settle or do not settle, and operational changes (a TPA transition, a new claims manager, a shift in settlement authority) alter the trajectory the annual study assumed. If twelve months pass before anyone checks whether actual development matches the projection, the reserve can drift materially in either direction without anyone noticing until the next full study delivers a surprise.

Interim monitoring exists to close that gap. It is the structured, periodic comparison of actual claims experience against the expectations embedded in the most recent full analysis. Done well, it converts the annual opinion from a once-a-year event into a continuously validated estimate, and it gives the buyer early warning when something is moving off track.

This article explains what interim monitoring is, how it works in practice, where it adds value, and what you should require from your actuary if you engage them for it. It is written for the risk manager, CFO, captive board member, or finance director who is deciding whether quarterly monitoring is worth the cost, or who already receives it and wants to know whether they are getting what they should.

What interim monitoring actually is

A full annual reserve study builds the estimate from the ground up. The actuary collects updated triangles, selects age-to-age factors, chooses methods by accident year, applies trend assumptions, and produces a new set of ultimate claim estimates. That process typically takes several weeks, involves significant actuarial judgment, and produces a formal report with documentation meeting the requirements of ASOP 43 and ASOP 9.

Interim monitoring does something different. It starts from the conclusions of the most recent full study and asks a single question: is actual experience tracking the projection, or has something changed?

Friedland frames this as the comparison of actual development against what the annual analysis predicted (p. 345). The actuary takes the quarterly (or sometimes monthly) data extract, measures how paid and reported claims have moved since the last measurement date, and compares that movement against the development the full study’s selected factors implied. If the actual movement is consistent with the projection, the carried reserve is still supportable. If the actual movement diverges, the actuary flags the divergence, diagnoses the likely cause, and recommends whether the carried reserve needs adjustment before the next full study.

The distinction matters because interim monitoring is not a second opinion. It is a calibration check on the first one. The full study sets the baseline; the interim review measures drift from that baseline. This makes it faster, less expensive, and narrower in scope than a full study, but it also means the interim review is only as good as the annual study it monitors against. A flawed baseline produces flawed monitoring.

The mechanics: how the comparison works

To make the concept concrete, consider a simplified workers compensation program with a single open accident year.

Suppose the most recent full study, completed as of December 31, 2025, estimated ultimate losses for accident year 2025 at $4,000,000. At that valuation date, cumulative paid losses were $1,200,000 and cumulative reported losses (paid plus case outstanding) were $2,400,000. The study selected a reported loss development factor of 1.667 from the 24-month maturity to ultimate, implying that 60% of ultimate losses had been reported (1 / 1.667 = 0.60) and 40% remained as broad IBNR.

The study also selected a paid development factor of 3.333 from 24 months to ultimate, implying that about 30% of ultimate losses had been paid.

Now suppose the actuary performs an interim monitoring review as of March 31, 2026, three months later. The program’s data shows:

Cumulative paid losses: $1,500,000 (up $300,000 from December)
Cumulative reported losses: $2,700,000 (up $300,000 from December)

The actuary’s task is to compare this movement against the expected movement. The annual study’s selected development pattern implies a certain amount of paid and reported emergence between 24 and 27 months of maturity. If the selected pattern anticipated roughly $280,000 of paid emergence and $320,000 of reported emergence in that quarter, then:

Actual paid emergence ($300,000) is slightly above expectation ($280,000): a modest variance, likely within normal range.
Actual reported emergence ($300,000) is slightly below expectation ($320,000): also a modest variance.

The actuary would note both variances, assess whether either exceeds a materiality threshold, and conclude that, for this quarter, actual experience is tracking the annual projection. No adjustment is recommended.

But suppose instead that cumulative reported losses at March 31 had jumped to $3,200,000, an increase of $800,000 in a single quarter against an expectation of $320,000. That gap is too large to attribute to normal volatility. The actuary would flag the divergence and investigate: Did a single large claim drive the increase? Did the TPA conduct a case reserve adequacy review that strengthened open cases? Did a batch of new claims arrive from a previously unreported incident? Each explanation implies a different response, and the interim monitoring report should diagnose the cause, not just measure the gap.

If the cause is a case reserve strengthening across the book (the TPA raised reserves on many claims simultaneously), the actuary might conclude that the ultimate has not changed but the reported triangle now reflects a higher case adequacy level. That shift would distort a naive reported chain ladder projection but does not necessarily mean the program owes more money. Alternatively, if the cause is genuine adverse development (new claims, higher severity on existing claims), the actuary would recommend increasing the carried reserve.

This is the core value of interim monitoring: early diagnosis. Rather than discovering twelve months later that the reserve was understated for an entire year, the buyer learns within a quarter that something has shifted and can act accordingly.

When interim monitoring adds the most value

Interim monitoring is most valuable when the program has characteristics that make the annual estimate fragile or the stakes of being wrong between opinions are high.

Long-tail lines with high per-claim severity. Workers compensation, general liability, professional liability, and auto bodily injury all develop over multiple years. A single large claim that settles (or fails to settle) can move the reserve materially. Quarterly monitoring catches these movements in real time rather than retroactively.

Programs with recent operational changes. If the program switched TPAs, changed settlement authority, implemented a new medical management protocol, or experienced a leadership change in the claims department, the annual study’s assumptions about future development may be invalidated within months. Interim monitoring provides the first read on whether the change is producing the expected effect or something else entirely. The diagnostic framework used in a full study applies here in a lighter form: the actuary checks whether known operational changes are showing up in the data as anticipated.

Programs approaching a renewal, funding decision, or board presentation. If the CFO is setting next year’s budget in September and the annual study was completed in March, six months of unmonitored development separates the reserve estimate from the funding decision. An interim review at June 30 provides a validated, current number for the budget process rather than forcing the CFO to rely on a stale estimate or an unstructured guess.

Captive programs with regulatory reporting requirements. Many captive domiciles require quarterly financial statements. An interim monitoring engagement gives the captive manager a defensible basis for the carried reserve on each quarterly filing rather than simply rolling forward the annual number unchanged.

When interim monitoring is not enough

Interim monitoring is a calibration tool, not a replacement for the annual full study. It has structural limits that buyers should understand.

It does not revisit method selection. The annual study chose chain ladder for mature years and Bornhuetter-Ferguson for recent years. The interim review measures actual development against those methods’ projections but does not re-evaluate whether those methods are still the right ones. If a structural change (a major shift in claim mix, a new line of coverage, a policy limit change) makes a different method more appropriate, only the full study can address that.

It does not update trend assumptions. Trend selections (severity trend, frequency trend, loss ratio trend) are set in the annual study and held constant during interim monitoring. If the trend environment changes materially between studies (for example, medical inflation accelerates beyond the selected trend), the interim review will measure development against an increasingly stale baseline.

It relies on timely, accurate data. If the TPA’s quarterly data extract is late, incomplete, or inconsistent with the data used in the annual study, the comparison breaks down. Data reconciliation is a prerequisite, not an afterthought.

It cannot substitute for a new opinion. In some contexts (regulatory filings, captive domicile requirements, large transactions), stakeholders require a formal actuarial opinion, not a monitoring update. Interim monitoring produces a memorandum or letter, not a Statement of Actuarial Opinion. The distinction matters for compliance and audit purposes.

The self-insured wrinkle

For self-insured programs, interim monitoring solves a problem that carriers manage internally but that self-insureds often neglect.

Carriers have internal actuarial staff reviewing reserve adequacy monthly. The reserving actuary, the pricing actuary, and the claims leadership meet regularly to discuss development. The monitoring function is embedded in the operating structure.

Self-insured programs typically have none of that infrastructure. The risk manager manages claims operationally. The CFO manages the financial reporting. The actuary appears once a year, produces a report, and disappears until the next engagement. Between opinions, nobody is watching whether the reserve is still right.

This gap is especially dangerous for programs with thin data and leveraged development factors. A small self-insured program with fifty claims per accident year can see its reserve swing by 20% or more on a single large claim settlement. If that settlement occurs in January and the next full study is not completed until the following December, the balance sheet carries a materially wrong number for nearly a year.

Interim monitoring converts the actuarial relationship from transactional (one report per year) to advisory (ongoing validation). The actuary becomes a partner in the monitoring process rather than a vendor who delivers a point-in-time product. For self-insured programs where the stakes of being wrong are concentrated in a small number of high-severity claims, this ongoing relationship is often more valuable than the annual study itself.

What a buyer should ask their actuary

If you are considering adding interim monitoring to your actuarial engagement, or if you already receive it and want to evaluate whether it is working, ask these questions:

What is the comparison basis? The actuary should be measuring actual paid and reported emergence against the specific development patterns selected in the most recent full study. If the interim review uses a different pattern or benchmark, ask why.
What materiality threshold triggers a recommendation? Not every variance requires action. The actuary should have a defined threshold (expressed as a percentage of carried reserves or a dollar amount) above which a variance is flagged and investigated. Ask what that threshold is and how it was set.
Does the review diagnose the cause of divergence, or just measure the gap? A monitoring report that says “reported losses are 15% above expectation” without explaining whether the cause is case strengthening, new claim frequency, or a single large loss is not useful. Diagnosis is the point.
How are large claims handled? A single claim that jumps from $200,000 to $2,000,000 can dominate the quarter’s development. The monitoring review should isolate large-claim movements from attritional development so the buyer can understand what is driving the variance.
What data reconciliation is performed? The actuary should confirm that the quarterly data extract reconciles to the data used in the annual study. Changes in TPA coding, claim numbering, or valuation date conventions can create false signals if the data is not reconciled.

What to require in documentation

An interim monitoring deliverable is not a full report, but it should still be structured and documented. At minimum, require:

Comparison of actual vs. expected development, by accident year, for both paid and reported triangles. The expected development should tie directly to the annual study’s selected factors.
Variance analysis that separates large-claim development from attritional development.
Diagnosis of material variances, including the actuary’s assessment of whether the variance reflects a temporary fluctuation or a trend that may persist.
Recommendation on whether the carried reserve should be adjusted. If no adjustment is recommended, the report should state that explicitly and explain why.
Identification of emerging issues that may not yet be large enough to trigger a reserve change but that the actuary wants to flag for continued monitoring. This includes early indicators of adverse development such as shifts in reporting lag, attorney involvement rates, or closure rates.
Data reconciliation confirmation that the quarterly extract is consistent with the annual study’s data.

If your actuary provides interim monitoring as a phone call and a paragraph of email, you are not getting what you are paying for. The documentation does not need to be long, but it needs to be structured enough that someone other than the actuary can read it and understand what happened, what it means, and what was recommended.

Frequency and cost

Most programs that use interim monitoring do so quarterly, producing three interim reviews between annual studies. Some programs with volatile lines or upcoming transactions monitor monthly, though this is less common.

The cost of interim monitoring is typically a fraction of the annual study, because the actuary is not rebuilding the analysis from scratch but rather updating it with new data and measuring deviations. For a mid-sized self-insured program, expect the quarterly monitoring engagement to cost roughly 15% to 30% of the annual study fee per quarter, depending on the number of lines and the complexity of the program structure.

The return on that cost is measured in avoided surprises: earlier detection of adverse development, better-informed funding decisions, more defensible quarterly financial statements, and a reserve that reflects current reality rather than a twelve-month-old snapshot.